Bilateral sensorineural hearing loss from danazol therapy. A case report.

Area of Science:

• Otolaryngology
• Pharmacology
• Neurology

Background:

• Danazol is frequently prescribed for various medical conditions.
• Adverse reactions to danazol are typically minor and reversible.
• A growing number of medications are known to cause ototoxicity, but danazol has not been previously implicated.

Observation:

• A case study investigated a patient experiencing bilateral sensorineural hearing loss.
• The patient was undergoing therapy with danazol for an unspecified condition.

Findings:

• The hearing loss was directly attributed to danazol treatment.
• Prompt cessation of danazol therapy led to a complete recovery of hearing function.

Implications:

• This case suggests danazol as a potential cause of drug-induced hearing loss.
• Clinicians should consider danazol when evaluating patients with unexplained sensorineural hearing loss.
• Further research may be warranted to explore the ototoxic potential of danazol.